Provider
Afrezza (regular human insulin, inhaled) - Commercial
Prior Authorization, Quantity Limit
Program effective Date: Apr 01, 2026
Documents & Forms Results
Displaying 3531 - 3540 of 3677 results
Provider
Hereditary Angioedema - Commercial
Prior Authorization, Quantity Limit
Program effective Date: Apr 01, 2026
Provider
Leqembi - Commercial
Prior Authorization, Quantity Limit
Program effective Date: Apr 01, 2026
Provider
Furoscix (furosemide) - Commercial
Prior Authorization, Quantity Limit
Program effective Date: Apr 01, 2026
Provider
Factor VIII and von Willebrand Factor - Commercial
Prior Authorization, Quantity Limit
Program effective Date: Apr 01, 2026
Provider
Duvyzat - Commercial
Prior Authorization, Quantity Limit
Program effective Date: Apr 01, 2026
Provider
Weight Management - Commercial
Prior Authorization, Quantity Limit
Program effective Date: Apr 01, 2026
Provider
Alternative Dosage Form - Commercial
Prior Authorization, Quantity Limit
Program effective Date: Apr 01, 2026
Provider
Saxenda Wegovy Zepbound - Commercial
Coverage Exception, Formulary Exception
Program effective Date: Apr 01, 2026